» Articles » PMID: 34641874

Systematical Analysis Reveals a Strong Cancer Relevance of CREB1-regulated Genes

Overview
Journal Cancer Cell Int
Publisher Biomed Central
Date 2021 Oct 13
PMID 34641874
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

The transcription factor cyclic-AMP response element-binding protein 1 (CREB1) responds to cAMP level and controls the expression of target genes, which regulates nutrition partitioning. The promoters of CREB1-targeted genes responsive to cAMP have been extensively investigated and characterized with the presence of both cAMP response element and TATA box. Compelling evidence demonstrates that CREB1 also plays an essential role in promoting tumor development. However, only very few genes required for cell survival, proliferation and migration are known to be constitutively regulated by CREB1 in tumors. Their promoters mostly do not harbor any cAMP response element. Thus, it is very likely that CREB1 regulates the expressions of distinct sets of target genes in normal tissues and tumors. The whole gene network constitutively regulated by CREB1 in tumors has remained unrevealed. Here, we employ a systematical and integrative approach to decipher this gene network in the context of both tissue cultured cancer cells and patient samples. We combine transcriptomic, Rank-Rank Hypergeometric Overlap, and Chipseq analysis, to define and characterize CREB1-regulated genes in a multidimensional fashion. A strong cancer relevance of those top-ranked targets, which meet the most stringent criteria, is eventually verified by overall survival analysis of cancer patients. These findings strongly suggest the importance of genes constitutively regulated by CREB1 for their implicative involvement in promoting tumorigenesis.

Citing Articles

CREB1 promotes cholangiocarcinoma metastasis through transcriptional regulation of the LAYN-mediated TLN1/β1 integrin axis: CREB1 promotes cholangiocarcinoma metastasis through regulating LAYN/TLN1/β1 integrin axis.

Liang S, Zhou S, Tang Y, Xiao M, Ye K Heliyon. 2024; 10(17):e36595.

PMID: 39286102 PMC: 11402943. DOI: 10.1016/j.heliyon.2024.e36595.


Targeting the peripheral neural-tumour microenvironment for cancer therapy.

Yaniv D, Mattson B, Talbot S, Gleber-Netto F, Amit M Nat Rev Drug Discov. 2024; 23(10):780-796.

PMID: 39242781 DOI: 10.1038/s41573-024-01017-z.


High-throughput characterization of functional variants highlights heterogeneity and polygenicity underlying lung cancer susceptibility.

Long E, Patel H, Golden A, Antony M, Yin J, Funderburk K Am J Hum Genet. 2024; 111(7):1405-1419.

PMID: 38906146 PMC: 11267514. DOI: 10.1016/j.ajhg.2024.05.021.


The Circular RNA Circ_0043947 Promoted Gastric Cancer Progression by Sponging miR-384 to Regulate CREB1 Expression.

Zhang C, Zhang F, Li Y, Yang P, Liu Y, Yang W Gut Liver. 2024; 18(6):977-991.

PMID: 38638101 PMC: 11565005. DOI: 10.5009/gnl230173.


Uncharacterized Proteins CxORFx: Subinteractome Analysis and Prognostic Significance in Cancers.

Ershov P, Yablokov E, Mezentsev Y, Ivanov A Int J Mol Sci. 2023; 24(12).

PMID: 37373333 PMC: 10298883. DOI: 10.3390/ijms241210190.


References
1.
Xiang X, Zhao X, Pan X, Dong Z, Yu J, Li S . Efficient correction of Duchenne muscular dystrophy mutations by SpCas9 and dual gRNAs. Mol Ther Nucleic Acids. 2021; 24:403-415. PMC: 8039775. DOI: 10.1016/j.omtn.2021.03.005. View

2.
Sun S, Liu D, Deng Y, Zhang X, Wan D, Xi B . SIX1 coordinates with TGFβ signals to induce epithelial-mesenchymal transition in cervical cancer. Oncol Lett. 2016; 12(2):1271-1278. PMC: 4950046. DOI: 10.3892/ol.2016.4797. View

3.
Xie S, Price J, Luca M, Jean D, Ronai Z, Bar-Eli M . Dominant-negative CREB inhibits tumor growth and metastasis of human melanoma cells. Oncogene. 1997; 15(17):2069-75. DOI: 10.1038/sj.onc.1201358. View

4.
Anand A, Liu B, Giacobini J, Maeda K, Rohde M, Jaattela M . Cell Death Induced by Cationic Amphiphilic Drugs Depends on Lysosomal Ca Release and Cyclic AMP. Mol Cancer Ther. 2019; 18(9):1602-1614. PMC: 7611280. DOI: 10.1158/1535-7163.MCT-18-1406. View

5.
Abbott N, Nicholson C, Verkhratsky A . Introduction: Special Issue in Honor of Eva Syková. Neurochem Res. 2019; 45(1):1-4. DOI: 10.1007/s11064-019-02924-z. View